Carvedilol v placebo in acute management of myocardial infarction (MI) at a mean of 1.3 years‡
| Outcomes | Carvedilol | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| ‡Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| All-cause mortality | 12% | 15% | 22% (3 to 38) | 30 (16 to 244) |
| Cardiovascular mortality | 11% | 14% | 24% (4 to 40) | 29 (16 to 185) |
| Non-fatal MI | 3% | 6% | 40% (9 to 60) | 44 (24 to 223) |
| All-cause mortality or non-fatal MI | 14% | 20% | 27% (11 to 40) | 20 (12 to 52) |